Bioquell displays decontamination options

31-Mar-2006

UK-based Bioquell has developed a unique and patent-protected range of hydrogen peroxide vapour (HPV) bio-decontamination systems for the bio-deactivation of micro-organisms, including bacteria, viruses and fungi in the healthcare, pharmaceutical, biotechnology and food industries.

UK-based Bioquell has developed a unique and patent-protected range of hydrogen peroxide vapour (HPV) bio-decontamination systems for the bio-deactivation of micro-organisms, including bacteria, viruses and fungi in the healthcare, pharmaceutical, biotechnology and food industries.

The PORT is the latest addition to the Clarus range, offering rapid sporicidal gassing systems for a new generation of aseptic processing modules. It is designed to accommodate small-scale aseptic compounding techniques for pharmacy operations and also sterility test applications, as well as interfacing with transfer chambers and "through-the-wall" applications.

With efficacy and safety issues making the use of aldehydes increasingly unacceptable, hydrogen peroxide vapour provides a safe and effective alternative. Hydrogen peroxide vapour (H2O2) is non-carcinogenic, safe and efficacious against a wide range of viruses, bacteria and moulds offering clear advantages over other techniques such as formaldehyde, peracetic acid fogging or the nebulising of toxic biocides. H2O2 vapour breaks down under catalytic action making it environmentally friendly, leaving no residues, unlike many other biocides.

Bioquell has introduced the Equipment Bio-Decontamination Service (EBDS), taking advantage of the latest developments in H2O2 gassing technology for the routine and emergency decontamination of enclosures, biological safety cabinets, incubators and other laboratory equipment.

Hall 4.1, Stand P34 and Hall 5.1, Stand D16